Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
S Faiz, J Giovannelli, C Podevin, M Jachiet… - Journal of the American …, 2019 - Elsevier
Background Dupilumab is the first biologic available to treat atopic dermatitis (AD). Its
effectiveness and safety were demonstrated in clinical trials. Objective We sought to assess
the effectiveness and safety of dupilumab in adults with AD in a real-life French multicenter
retrospective cohort. Methods We included patients treated during March 2017-April 2018.
Efficacy outcomes, including Scoring Atopic Dermatitis (SCORAD) and Eczema Area and
Severity Index (EASI) scores, were collected at baseline and 3 months when available …
effectiveness and safety were demonstrated in clinical trials. Objective We sought to assess
the effectiveness and safety of dupilumab in adults with AD in a real-life French multicenter
retrospective cohort. Methods We included patients treated during March 2017-April 2018.
Efficacy outcomes, including Scoring Atopic Dermatitis (SCORAD) and Eczema Area and
Severity Index (EASI) scores, were collected at baseline and 3 months when available …